A Study of Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)

Clinical trial NCT01006980 · COMPLETED

Trial details

NCT number: NCT01006980
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2010-01-01
Primary completion: 2010-12-01
Enrollment: 675

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.